resveratrol has been researched along with 4-dimethylaminostilbene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deck, LM; Gonzales, AM; Heynekamp, JJ; Hunsaker, LA; Jagt, DL; Orlando, RA; Weber, WM | 1 |
| Chen, X; Evers, BM; Kril, LM; Liu, C; Rychahou, P; Shi, J; Sviripa, V; Watt, DS; Yu, T; Zhang, W | 1 |
2 other study(ies) available for resveratrol and 4-dimethylaminostilbene
| Article | Year |
|---|---|
Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB.
Topics: Antioxidants; Cell Line; Combinatorial Chemistry Techniques; Cyclooxygenase 2 Inhibitors; Humans; NF-kappa B; Resveratrol; Stereoisomerism; Stilbenes; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2006 |
Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Resveratrol; Signal Transduction; Stereoisomerism; Stilbenes; Structure-Activity Relationship; Transplantation, Heterologous; Wnt Proteins | 2011 |